Tops & Flops Stocks
Security | Change (%) ▲ | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Nanorepro AG | -6.350% | -1.096% | 1.690% | -14.455% | -12.379% | -81.563% | 55.603% |
Mediwound Ltd. | -6.320% | -5.780% | 13.194% | 75.269% | 81.111% | 360.452% | 322.170% |
Palatin Technologies Inc. | -6.310% | 8.651% | 20.571% | 3.431% | -38.663% | -80.531% | -93.344% |
Microbix Biosystems | -6.310% | - | - | - | - | - | - |
Orpea Nom. | -6.150% | - | - | - | - | - | - |
Mednax Inc | -6.060% | -7.186% | -10.405% | -36.992% | -8.284% | -70.420% | -70.448% |
Strata Skin Sciences Inc. | -6.020% | -3.704% | -19.588% | -66.631% | -36.066% | -76.000% | -86.207% |
IXICO | -5.920% | -7.018% | -13.115% | -62.500% | -41.544% | -92.902% | - |
Abeona Therapeutics Inc. | -5.770% | -8.879% | -43.478% | 33.015% | -17.197% | -85.818% | - |
G1 Therapeutics | -5.740% | 7.302% | 2.636% | 64.370% | 61.382% | -72.723% | - |
EyePoint Pharmaceuticals Inc. | -5.710% | -38.816% | -44.508% | 91.709% | -47.593% | 53.630% | - |
Akebia Therapeutics Inc. | -5.620% | -12.373% | -22.668% | 19.807% | -4.522% | -53.375% | - |
Ocular Therapeutix Inc. | -5.620% | -8.170% | -28.513% | -10.923% | 25.357% | -57.920% | 62.396% |
BioLase Inc. | -5.520% | - | - | - | - | - | - |
Hexo Corp. | -5.340% | - | - | - | - | - | - |
Aldeyra Therapeutics Inc. | -5.340% | -9.573% | -11.541% | -62.460% | 7.605% | - | - |
Rigel Pharmaceutical Inc. | -5.310% | -17.552% | -20.139% | -15.107% | -34.053% | -64.971% | - |
Axogen Inc | -5.310% | - | - | - | - | - | - |
Chimerix Inc. | -5.200% | 0.787% | -6.178% | -11.898% | 6.743% | -86.424% | -65.095% |
Erytech Pharma S.A. | -5.170% | - | - | - | - | - | - |
Prescient Therapeutics Ltd. | -5.170% | - | - | - | - | - | - |
Brookdale Sr Lvg | -5.150% | -3.731% | 3.200% | 80.168% | 19.444% | 7.500% | 2.300% |
BeiGene Ltd ADR | -5.100% | -0.662% | 7.914% | -33.036% | -9.091% | -40.000% | - |
Lumos Pharma Inc. | -4.960% | -2.878% | 7.143% | -8.163% | -7.534% | -74.286% | -80.916% |
Paion AG | -4.910% | - | - | - | - | - | - |